Precautions:
The dressing should not be placed over infected wounds. This device is not intended to treat Surgical Site Infections (SSl's) or other percutaneous device-related infections. This device has not been studied in a randomized clinical study to determine its effectiveness in preventing such infections.
Active bleeding at wound sites should be stabilized before applying the dressing.
Do not stretch the dressing before applying it to the skin. Dressings applied under tension can cause trauma to the skin.
To ensure good adhesion and to help prevent skin irritation, remove detergent residues and allow all skin preparations and protectants to dry completely before applying the dressing to the skin.
Caution: Federal (USA) law restricts this device to sale by or on the order of a licensed healthcare practitioner.
For proper use, clinicians should be trained in the use of this device.
Warnings:
- ReliaTect® Post-Op Dressing with CHG should not be used as a replacement for sutures and other primary wound closure methods.
- ReliaTect® Post-Op Dressing with CHG should not be used on third-degree burns.
- DO NOT USE ReliaTect® Post-Op Dressing with CHG on premature infants or infants younger than two months of age. Use of this product and premature infants may result in hypersensitivity reactions or necrosis of the skin.
- ReliaTect® Post-Op Dressing with CHG should not be used as a primary means to fix arterial catheters or arterial cannulae.
- For external use only. Do not allow contact of this device with ears, eyes, mouth or mucous membranes.
- Do you not use this device on patients with a known hypersensitivity to chlorhexidine gluconate. Adverse reactions such as irritations, sensitization and generalized allergic reactions have been reported with the use of chlorhexidine gluconate.
- If allergic reactions can cure, discontinue use immediately and, if severe, contact a physician.
- Stop using the ReliaTect® Post-Op Dressing with CHG if the patient experiencing symptoms such as: wheezing or difficulty breathing, swelling face, hives that quickly progress to more serious symptoms, severe rash or shock (which is a life-threatening condition that occurs when the body is not getting enough blood flow). These symptoms are associated with an allergic reaction to CHG.
- Patients must be questioned about any prior allergic reactions to a medical device containing Chlorhexidine Gluconate. ALTERNATIVES MUST BE CONSIDERED UNDER SUCH CIRCUMSTANCES.
- Literature searches found hypersensitivity reactions associated with the topical use of chlorhexidine gluconate have been reported in several countries. Caution should be used when using chlorhexidine containing preparations, and the patient should be observed for the possibility of hypersensitivity reactions.
- Do not use on immune compromised patients or patients with underlying skin pathology which compromises the epidermal barrier. Use of this product may result in erosive contact dermatitis.
- Do not use ReliaTect Post-Op Dressing over surface based adhesive wound closures.
- Intended for a single patient use only.
- Do not reuse. As with all adhesive-based products, adhesive effectiveness and functionality can decline after the first use in the product will not perform as specified. Reuse may lead to infection or other illness/injury.
- Store in a cool, dry place. Keep away from direct sunlight. Do not store above 25°C/77°F. Do not use of packaging is damaged. Do not resterilize.
References:
1. Denton, Graham. “Chlorhexidine.” In Block, S., editor. Disinfection, Sterilization and Preservation, 5th edition. Philadelphia: Lippincott, Williams & Wilkins, 2001, 321-336.